We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.
- Authors
Macías, Juan; Neukam, Karin; Mallolas, Josep; López-Cortés, Luis F; Cartón, José A; Domingo, Pere; Moreno, Santiago; Iribarren, José A; Clotet, Bonaventura; Crespo, Manell; de Los Santos, Ignacio; Ortega, Enrique; Knobel, Hernando; Jiménez-Expósito, María J; Pineda, Juan A; COINS Study Team
- Abstract
To evaluate the incidence and risk factors for grade 3 or 4 ALT or AST elevations (TE) and grade 4 total bilirubin elevations (TBE) among HIV/HCV- coinfected treatment-naïve patients with an initial regimen including 2 nucleoside analogs plus efavirenz (EFV), nevirapine (NVP), or a ritonavir-boosted protease inhibitor (PI/r).
- Publication
HIV clinical trials, 2012, Vol 13, Issue 2, p61
- ISSN
1528-4336
- Publication type
Journal Article
- DOI
10.1310/hct1302-61